Article
IGF1-R signals through the RON receptor to mediate pancreatic cancer cell migration
11 May 2011
Abstract excerpt
The RON receptor tyrosine kinase (RTK) is overexpressed in the majority of pancreatic cancers, yet its role in pancreatic cancer cell biology remains to be clarified. Recent work in childhood sarcoma identified RON as a mediator of resistance to insulin-like growth factor receptor (IGF1-R)-directed therapy. To better understand RON function in pancreatic cancer cells, we sought to identify novel RON interactants....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
